July 26, 2016
1 min read
Save

Eyes with severe ocular surface disease at risk for KPro-related melt complications

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with severe ocular surface disease who underwent implantation of a Boston type 1 keratoprosthesis had a greater risk of developing corneal melts, leaks and extrusions, according to a study.

The retrospective study included 128 eyes of 110 patients who underwent Boston type 1 keratoprosthesis (KPro) implantation at the Cincinnati Eye Institute between 2004 and 2010. Mean follow-up time was 29 months.

Twenty eyes (16%) of 18 patients developed KPro-related melt complications that required surgery, of which seven eyes had multiple episodes. A total of 33 episodes of melt-related complications occurred.

Melt-related complications occurred at a mean time of 13 months after KPro implantation. Mean time to a melt complication was 11 months in patients with conjunctival deficiency and 16 months in patients without conjunctival deficiency.

Most melt-related complications were managed by performing a lamellar corneal patch grafting technique. Other repairs included KPro removal with penetrating keratoplasty, KPro removal with reassembly onto a new cornea for implantation, KPro removal with a replacement KPro, suture closure of the leak and enucleation. Eighteen of the eyes did not regain their best KPro vision.

Previous infectious keratitis (P < .0001) and conjunctival deficiency such as Stevens-Johnson syndrome, mucous membrane pemphigoid or chemical injury (P = .043) were significant risk factors for melt.

“Because of the increased complication rate in severe ocular surface disease, we prefer an ocular surface stem cell transplant as a primary procedure if at all possible especially in younger patients,” the study authors said. “A KPro as a secondary procedure can always be performed if the former procedure fails.” – by Nhu Te

Disclosure: Chan reports she has received honoraria from Allergan, Bausch + Lomb, and Alcon Laboratories. See the full study for all other authors’ relevant financial disclosures.